Search Results 1431-1440 of 19401 for hemoglobin

1. A Study of Rucaparib Verses Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency - Mayo Clinic

   Hemoglobin ≥ 10 g/dL independent of transfusion within 14 days. Hepatic Function: Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 3 ...

2. A Study Evaluating Temozolomide vs. Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma - Mayo Clinic

   Hemoglobin ≥ 10 mg/dL* ;; Total Bilirubin ≤ 1.5 x upper limit of normal (ULN)** ;; AST/ALT ≤ 3.0 x ULN;; Creatinine < 1.5 x ULN OR Calc. Creatinine ...

3. A Study to Evaluate Binimetinib in Combination with Encorafenib in Patients with Pancreatic Malignancies and a Somatic BRAFV600E Mutation - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL (obtained ≤ 14 days prior to registration). Total bilirubin ≤ 1.5 x upper limit of normal (ULN) (obtained ≤ 14 days prior to ...

4. Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors - Mayo Clinic

   Hemoglobin > 9 g/dL. Leukocytes ≥ 3,000/mcL. Absolute neutrophil count ≥ 1,500/mcL without the use of hematopoietic growth factors. Platelets ≥ 100,000 ...

5. A Study to Evaluate the Effectiveness and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma - Mayo Clinic

   Hemoglobin | ≤ 9.0 g/dL (transfusion allowed with 2-week washout period);; ANC | ≤ 1.5 × 109/L. Hepatic. ALT | > 2.5 × ULN (> 5 × ULN if related to ...

6. Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer - Mayo Clinic

   Hemoglobin ≥ 85 mg/mL; Bilirubin ≤ 2 mg/dL; ALT and AST ≤ 5 X upper limit of normal; Amylase and lipase 1,5 X upper limit of normal; Serum creatinine ≤ 1.5 ...

7. Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination with Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer - Mayo Clinic

   Hemoglobin ≥9 g/dL; Platelets ≥100x109/L; Prothrombin time /International normalized ratio (INR) and partial thromboplastin time ≤1.3xULN (Subjects ...

8. Endocarditis - Diagnosis & treatment - Mayo Clinic

   Learn what causes this infection of the inner lining of the heart chambers and valves (endocardium) and find out how to prevent and treat it.

9. A Study to Evaluate the Veniti Vici™ Venous Stent System in Patients with a Chronic Iliofemoral Venous Outflow Obstruction - Mayo Clinic

   Uncorrected hemoglobin of ≤ 9 g/dL. Has an estimated glomerular filtration rate (eGFR) <30 mL/min. In patients with diabetes mellitus, eGFR <45 mL/min. Has ...

10. Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma - Mayo Clinic

    Hemoglobin ≥ 9 g/dL, without transfusion support within 7 days preceding the lab assessment (obtained ≤ 14 days prior to registration). Activated partial ...